Solution-phase parallel synthesis and biological evaluation of combretatriazoles

J Comb Chem. 2008 Sep-Oct;10(5):732-40. doi: 10.1021/cc800090d. Epub 2008 Aug 6.

Abstract

Combretastatin A-4 is an antitumoral and antitubulin agent that is active only in its cis configuration. In the present manuscript, we have synthesized cis-locked combretastatins containing a triazole ring (combretatriazoles). To achieve this, we have developed a column chromatography-free parallel solution-phase synthesis that exploits the reaction between azides and alpha-keto phosphorus ylids, which is known to regioselectively generate the 1,5-disubstituted triazoles. The prepared compounds were screened as antitubulinic agents, allowing us to identify three new compounds with high potency, two of which show a new mechanism of action that induces cells to appear multinucleated and display a high number of mitotic spindles.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / chemical synthesis
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Catalysis
  • Cell Line, Tumor / drug effects
  • Cell Line, Tumor / pathology
  • Chromatography, High Pressure Liquid
  • Dose-Response Relationship, Drug
  • Inhibitory Concentration 50
  • Microscopy, Electron, Scanning
  • Ruthenium / chemistry
  • Solutions / chemistry
  • Stereoisomerism
  • Stilbenes / chemical synthesis
  • Stilbenes / pharmacology*
  • Structure-Activity Relationship
  • Triazoles / chemical synthesis
  • Triazoles / pharmacology*
  • Tubulin Modulators / chemical synthesis
  • Tubulin Modulators / pharmacology*

Substances

  • Antineoplastic Agents, Phytogenic
  • Solutions
  • Stilbenes
  • Triazoles
  • Tubulin Modulators
  • Ruthenium
  • fosbretabulin